CASE/0212/06/24 - Voluntary admission by Sanofi
Voluntary admission about an advertisement for Nexviadyme (avalglucosidasealfa) in a conference brochure
-
Received18 June 2024
-
Case numberCASE/0212/06/24
-
StatusBreach ruled, case report pending